Assessment of COVID-19 progression on day 5 from symptoms onset

Elisa Gentilotti(University of Verona), Evelina Tacconelli(World Health Organization), Dario Meneghin(University of Verona), Sara Mehrabi(University of Verona), Domenico Girelli(University of Verona), Elisa Razzaboni(University of Verona), Anna M. Górska(Kozminski University), Claudio Micheletto, Alessandro Visentin(University of Verona), Monica Compri(University of Verona), Elda Righi(Ospedale Santa Maria della Misericordia di Udine), Nicola Soriolo(University of Verona), Giorgia Be(University of Verona), Alessia Savoldi(University of Verona), Pasquale De Nardo(University of Verona)
BMC Infectious Diseases
August 28, 2021
10.1186/s12879-021-06596-5
Cited by 15

Related Papers

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance
|JAMA|2018|761
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
Differential regulation of iron homeostasis during human macrophage polarized activation
|European Journal of Immunology|2009|433
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm
|Nature Genetics|2010|217